
|Videos|December 10, 2020
Controlling postop pain, inflammation in cataract patients: drug delivery vs drops
Author(s)Alex Delaney-Gesing , David Hutton
John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.
Advertisement
John A. Hovanesian, MD, clinical instructor, UCLA Jules Stein Eye Institute, Laguna Hills, CA, discusses the highlights of his presentation titled "The D3 Study: Drug Delivery vs Drops — A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery," during the virtual 2020 American Academy of Ophthalmology (AAO) meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Alvotech files first known aflibercept 8 mg biosimilar with EMA
2
AAO 2026: How to become an ocular pain detective in dry eye
3
AAO 2026: Tinlarebant in Stargardt disease: Jacque Duncan, MD, on DRAGON results
4
AAO 2026: Vamikibart shows sustained gains in uveitic macular edema as FDA accepts BLA
5


















